Cargando…

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database

BACKGROUND: Real-world big data studies using health insurance claims databases require extraction algorithms to accurately identify target population and outcome. However, no algorithm for Crohn’s disease (CD) has yet been validated. In this study we aim to develop an algorithm for identifying CD u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morikubo, Hiromu, Kobayashi, Taku, Fukuda, Tomohiro, Nagahama, Takayoshi, Hisamatsu, Tadakazu, Hibi, Toshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513890/ https://www.ncbi.nlm.nih.gov/pubmed/34644342 http://dx.doi.org/10.1371/journal.pone.0258537

Ejemplares similares

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
por: Kobayashi, Taku, et al.
Publicado: (2019)

Usefulness of colestimide for diarrhea in postoperative Crohn's disease
por: Hojo, Aya, et al.
Publicado: (2022)

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023)

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
por: Hisamatsu, Tadakazu, et al.
Publicado: (2021)

First aid with color atlas for the use of intestinal ultrasound for inflammatory bowel disease in daily clinical practice
por: Miyoshi, Jun, et al.
Publicado: (2023)

Validation of a claims‐based algorithm to identify cases of ulcerative colitis in Japan
por: Ogino, Haruei, et al.
Publicado: (2021)

Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis
por: Kobayashi, Taku, et al.
Publicado: (2020)

Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4(+) T cells
por: Nishida, Atsushi, et al.
Publicado: (2012)

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
por: Takagi, Akira, et al.
Publicado: (2022)

Diagnostic Features of Perianal Fistula in Patients With Crohn’s Disease: Analysis of a Japanese Claims Database
por: Mizushima, Tsunekazu, et al.
Publicado: (2021)

Virtual patient identifier (vPID): Improving patient traceability using anonymized identifiers in Japanese healthcare insurance claims database
por: Sato, Jumpei, et al.
Publicado: (2023)

A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
por: Yokoyama, Kaoru, et al.
Publicado: (2016)

5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis
por: Wada, Haruka, et al.
Publicado: (2023)

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
por: Hibi, Toshifumi, et al.
Publicado: (2023)

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2020)

Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications
por: Ooba, Nobuhiro, et al.
Publicado: (2013)

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2019)

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2020)

Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database
por: Ooba, Nobuhiro, et al.
Publicado: (2018)

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
por: Yamazaki, Hajime, et al.
Publicado: (2019)

TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
por: Yoneno, Kazuaki, et al.
Publicado: (2013)

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database
por: Shima, Daisuke, et al.
Publicado: (2020)

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
por: Nakase, Hiroshi, et al.
Publicado: (2023)

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease
por: Ogata, Haruhiko, et al.
Publicado: (2016)

Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data
por: Takahashi, Sayumi, et al.
Publicado: (2022)

Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
por: Kobayashi, Taku, et al.
Publicado: (2021)

A machine-learning algorithm to identify hepatitis C in health insurance claims data
por: Khan, Mohammed A., et al.
Publicado: (2019)

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

A Systematic Review of Crohn’s Disease Case Definitions in Administrative or Claims Databases
por: Hutfless, Susan, et al.
Publicado: (2022)

Regional disparities in Dementia-free Life Expectancy in Japan: An ecological study, using the Japanese long-term care insurance claims database
por: Yoshikawa, Mikako, et al.
Publicado: (2023)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Improving IBD outcomes in the era of many treatment options
por: Kobayashi, Taku, et al.
Publicado: (2023)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

Predicting demand for long-term care using Japanese healthcare insurance claims data
por: Sato, Jumpei, et al.
Publicado: (2022)

Validation of an Algorithm to Identify Venous Thromboembolism in Health Insurance Claims Data Among Patients with Rheumatoid Arthritis
por: Kim, Sangmi, et al.
Publicado: (2023)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
por: Charbonnel, Bernard, et al.
Publicado: (2017)

The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ed9o9e4pbtt29pfcidae3b0pnr